Search Results - "Kusakabe, Yoshito"
-
1
Advanced lung cancer with recurrence of liver and tracheal metastases responsive to multimodality therapy - a case report
Published in Gan to kagaku ryoho (01-11-2014)“…We report a case of advanced lung cancer with recurrence of liver and tracheal metastases that were responsive to multimodality therapy. The patient was a…”
Get more information
Journal Article -
2
Large-cell neuroendocrine carcinoma of lung with epidermal growth factor receptor (EGFR) gene mutation and co-expression of adenocarcinoma markers: a case report and review of the literature
Published in Multidisciplinary respiratory medicine (18-07-2013)“…A high rate of response to treatment with epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) has been observed in certain patients (women,…”
Get full text
Journal Article -
3
Large-cell neuroendocrine carcinoma of lung with epidermal growth factor receptor (EGFR) gene mutation and co-expression of adenocarcinoma markers: a case report and review of the literature
Published in Multidisciplinary respiratory medicine (01-12-2013)“…Purpose: A high rate of response to treatment with epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) has been observed in certain patients…”
Get full text
Journal Article -
4
HEART PAP (adapted-servo ventilation; ASV) is effective for the ventilation of chronic heart failure patient with Cheyne-Stokes respiration
Published in Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society (01-11-2008)“…A 72-year-old man with chronic heart failure had received implantation with a pacemaker for type III sick sinus syndrome in 2002. Mixed type sleep apnea…”
Get more information
Journal Article -
5
Large-cell neuroendocrine carcinoma of lung with epidermal growth factor receptor (EGFR) gene mutation and co-expression of adenocarcinoma markers: a case report and review of the literature
Published in Multidisciplinary respiratory medicine (18-07-2013)“…PURPOSEA high rate of response to treatment with epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) has been observed in certain patients…”
Get full text
Report